相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
Joydeep Mukherjee et al.
CANCER RESEARCH (2018)
Telomeres in cancer: tumour suppression and genome instability
John Maciejowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Solving the Telomere Replication Problem
Laetitia Maestroni et al.
GENES (2017)
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
Stefan Pusch et al.
ACTA NEUROPATHOLOGICA (2017)
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
Uzay E. Emir et al.
CANCER RESEARCH (2016)
IDH mutations in cancer and progress toward development of targeted therapeutics
L. Dang et al.
ANNALS OF ONCOLOGY (2016)
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
Shigeo Ohba et al.
CANCER RESEARCH (2016)
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis
Tor-Christian Aase Johannessen et al.
MOLECULAR CANCER RESEARCH (2016)
Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis
Shigeo Ohba et al.
NEUROLOGIA MEDICO-CHIRURGICA (2016)
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
Joao P. Amorim et al.
GENES (2016)
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
Johanna Mondesir et al.
JOURNAL OF BLOOD MEDICINE (2016)
Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers
Koichi Ichimura et al.
ACTA NEUROPATHOLOGICA (2015)
Extreme Vulnerability of IDH1 Mutant Cancers to NAD plus Depletion
Kensuke Tateishi et al.
CANCER CELL (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
IDH1/2 mutation detection in gliomas
Hideyuki Arita et al.
BRAIN TUMOR PATHOLOGY (2015)
Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Kasthuri Kannan et al.
Oncotarget (2015)
Mutant IDH1-Driven Cellular Transformation Increases RAD51-Mediated Homologous Recombination and Temozolomide Resistance
Shigeo Ohba et al.
CANCER RESEARCH (2014)
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
Anuhar Chaturvedi et al.
BLOOD (2013)
Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition
Chong Chen et al.
GENES & DEVELOPMENT (2013)
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco et al.
LANCET ONCOLOGY (2013)
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
Chunzhi Zhang et al.
NEURO-ONCOLOGY (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
2-Hydroxyglutarate as a Magnetic Resonance Biomarker for Glioma Subtyping
Morteza Esmaeili et al.
TRANSLATIONAL ONCOLOGY (2013)
IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Hui Yang et al.
CLINICAL CANCER RESEARCH (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production
P. S. Ward et al.
ONCOGENE (2012)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
Inhibition of 2-oxoglutarate dependent oxygenases
Nathan R. Rose et al.
CHEMICAL SOCIETY REVIEWS (2011)
Alternative lengthening of telomeres: models, mechanisms and implications
Anthony J. Cesare et al.
NATURE REVIEWS GENETICS (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
分享论文
